Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV therapy in 2003: consensus and controversy.

Paul A Volberding1

  • 1University of California, San Francisco, California 94121, USA. Paul.Volberding@med.va.gov

AIDS (London, England)
|July 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

JAMA·2020
Same author

National Academies Consensus Report on Functional Assessment for Adults With Disabilities.

Archives of physical medicine and rehabilitation·2019
Same author

HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence.

JAMA·2019
Same author

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

JAMA·2018
Same author

Health impact of human rights testimony: harming the most vulnerable?

BMJ global health·2017
Same author

HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.

Topics in antiviral medicine·2017

Antiretroviral therapy offers significant benefits for HIV patients but poses challenges due to side effects and drug resistance. Addressing these issues is crucial for effective HIV management and treatment success.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • HIV therapy provides substantial clinical benefits, increasing patient engagement in care.
  • Antiretroviral drugs, while beneficial, are associated with frequent and sometimes irreversible short- and long-term toxicities.
  • Challenges in predicting and managing drug toxicities limit treatment accessibility and adherence.

Purpose of the Study:

  • To review the significant advantages of HIV therapy.
  • To discuss the ongoing challenges in the application of HIV treatment, including toxicity and drug resistance.

Main Methods:

  • Literature review of existing data on HIV therapy benefits and challenges.
  • Analysis of factors contributing to treatment failure, such as drug toxicity and adherence.

Related Experiment Videos

  • Examination of the relationship between therapy and the selection of drug-resistant HIV strains.

    • Main Results:

    • HIV therapy demonstrates clear clinical benefits, driving patient enrollment in treatment programs.
    • Frequent side effects and unpredictable toxicities of antiretroviral agents present significant barriers to treatment.
    • Inadequate medication adherence and resulting drug resistance contribute to incomplete viral suppression and virologic failure.

    Conclusions:

    • Despite the proven advantages of HIV therapy, managing side effects and preventing drug resistance remain critical challenges.
    • Further research is needed to improve toxicity prediction and develop more tolerable antiretroviral regimens.
    • Optimizing patient adherence and addressing drug resistance are essential for achieving long-term viral suppression and improving outcomes in HIV care.